Pharma & Biotech

The pharmaceutical giant's intensified focus on cancer research is yielding tangible results. Bristol-Myers Squibb is advancing its oncology pipeline through...

The survival of biotechnology firm Novavax hangs in the balance as activist investor Shah Capital escalates pressure on the company's...

Ocugen, Inc. witnessed a sharp 7% decline in its share price on Wednesday, a downturn driven by investor apprehension over...

Eli Lilly and Company has launched a remarkable strategic initiative, announcing three major transactions worth billions of dollars within days....

The proposed multi-billion euro acquisition of CureVac by BioNTech enters its final phase with two crucial November deadlines approaching. Shareholders...

Shares of Viking Therapeutics experienced significant upward momentum this week, fueled by renewed takeover speculation and a positive analyst update....

The Dow Jones Industrial Average surged to an unprecedented milestone on Wednesday, closing above 47,974 points for the first time...

The financial markets occasionally present puzzling scenarios where corporate achievements clash with investor behavior. Bionxt Solutions currently finds itself in...

Today marks a pivotal juncture for Applied Therapeutics as the biopharmaceutical firm prepares to release its third-quarter 2025 financial results....

After a prolonged period of disappointing its shareholders, the pioneering coronavirus vaccine developer is showing signs of a potential resurgence....